Wired AI
Google DeepMind employees have begun unionization talks, but the process is facing early difficulties. Employees expressed frustration with executives' perceived lack of meaningful engagement regarding the unionization effort. This signals potential challenges in establishing a union at the AI research lab.
Key Takeaways
- Google DeepMind employees are actively pursuing unionization.
- Initial negotiations are marked by employee dissatisfaction with executive responsiveness.
Why it matters:
The outcome of these unionization talks could set a precedent for labor relations within Google's advanced AI divisions.
Read Original →
Google DeepMind
Google DeepMind, a leader in artificial intelligence, has partnered with A24, a renowned film and television production company. This collaboration marks the first time a major AI research lab is joining forces with an entertainment company. The partnership aims to explore the intersection of AI and creative storytelling.
Key Takeaways
- Google DeepMind and A24 are collaborating on AI research.
- This is the first such partnership between a leading AI lab and an entertainment company.
Why it matters:
This groundbreaking partnership signals a significant step towards leveraging advanced AI for creative endeavors in the entertainment industry.
Read Original →
AI News
Takeda has partnered with Insilico Medicine in a strategic deal worth up to $600 million to leverage AI for early-stage drug discovery across its therapeutic areas. The collaboration grants Takeda access to Insilico's Pharma.AI platform, designed to accelerate the identification of biological targets for new drug development. While specific therapeutic areas and disease targets remain undisclosed, this partnership signifies a significant investment in AI-driven innovation within the pharmaceutical industry.
Key Takeaways
- Takeda is utilizing AI for early-stage drug discovery through a collaboration with Insilico Medicine.
- The deal, valued at up to $600 million, grants Takeda access to Insilico's AI platform.
Why it matters:
This significant investment highlights the growing role of AI in accelerating the complex and lengthy process of drug discovery within major pharmaceutical companies.
Read Original →